Neuronetics (STIM) Income from Continuing Operations (2017 - 2026)
Neuronetics' (STIM) quarterly Income from Continuing Operations came in at 11261000.0 in Q1 2026, up 13.96% year-on-year from 9881593.56 in Q1 2025, and down 70.13% on a QoQ basis from 6619000.0 in Q4 2025.
Neuronetics (STIM) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Income from Continuing Operations data on file, last reported at 11261000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 13.96% year-over-year to 11261000.0 in Q1 2026; TTM through Mar 2026 was 48172000.0, a 4.93% decrease from a year earlier, with the FY2025 full-year figure at 39851000.0, up 76.36% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 11261000.0, down from 6619000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for STIM reached as high as 6097000.0 in Q4 2023 and fell as low as 18193000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 10763352.94 across 5 years, with a median of 10137000.0 in 2024.
- Across the five-year window, Income from Continuing Operations surged 56.22% in 2022 and tumbled 116.98% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 9478000.0 in 2022, then jumped by 35.67% to 6097000.0 in 2023, then sank by 116.98% to 13229000.0 in 2024, then surged by 49.97% to 6619000.0 in 2025, then plunged by 70.13% to 11261000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 11261000.0 in Q1 2026, 6619000.0 in Q4 2025, and 12099000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | -11.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.26 Mn |
| Dec 31, 2025 | -6.62 Mn |
| Sep 30, 2025 | -12.10 Mn |
| Jun 30, 2025 | -18.19 Mn |
| Mar 31, 2025 | -13.09 Mn |
| Dec 31, 2024 | -13.23 Mn |
| Sep 30, 2024 | -9.45 Mn |
| Jun 30, 2024 | -10.14 Mn |
| Mar 31, 2024 | -8.69 Mn |
| Dec 31, 2023 | -6.10 Mn |
| Sep 30, 2023 | -10.06 Mn |
| Jun 30, 2023 | -8.35 Mn |
| Mar 31, 2023 | -11.16 Mn |
| Dec 31, 2022 | -9.48 Mn |
| Sep 30, 2022 | -8.71 Mn |
| Jun 30, 2022 | -11.09 Mn |
| Mar 31, 2022 | -15.27 Mn |
| Dec 31, 2021 | -7.26 Mn |
| Sep 30, 2021 | -12.79 Mn |
| Jun 30, 2021 | -25.33 Mn |